These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15259028)

  • 41. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection.
    Jin YP; Jindra PT; Gong KW; Lepin EJ; Reed EF
    Transplantation; 2005 Feb; 79(3 Suppl):S19-21. PubMed ID: 15699739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of anti‑HLA class I antibodies on the immunological properties of human glomerular endothelial cells and their modification by mTOR inhibition or GCN2 kinase activation.
    Eleftheriadis T; Pissas G; Crespo M; Filippidis G; Antoniadis N; Liakopoulos V; Stefanidis I
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA class I: an unexpected role in integrin β4 signaling in endothelial cells.
    Zhang X; Reed EF
    Hum Immunol; 2012 Dec; 73(12):1239-44. PubMed ID: 22789625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of rejection of allogeneic endothelial cells in a biohybrid lung by silencing HLA-class I expression.
    Wiegmann B; Figueiredo C; Gras C; Pflaum M; Schmeckebier S; Korossis S; Haverich A; Blasczyk R
    Biomaterials; 2014 Sep; 35(28):8123-33. PubMed ID: 24961166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies.
    Dorling A; Stocker C; Tsao T; Haskard DO; Lechler RI
    Transplantation; 1996 Oct; 62(8):1127-36. PubMed ID: 8900314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-HLA class I antibodies transduce signals in endothelial cells resulting in FGF receptor translocation, down-regulation of ICAM-1 and cell proliferation.
    Bian H; Reed EF
    Transplant Proc; 2001; 33(1-2):311. PubMed ID: 11266833
    [No Abstract]   [Full Text] [Related]  

  • 47. HLA class I antibody-mediated endothelial and smooth muscle cell activation.
    Zhang X; Valenzuela NM; Reed EF
    Curr Opin Organ Transplant; 2012 Aug; 17(4):446-51. PubMed ID: 22710387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern.
    Reyes-Vargas E; Pavlov IY; Martins TB; Schwartz JJ; Hill HR; Delgado JC
    J Clin Lab Anal; 2009; 23(3):157-60. PubMed ID: 19455634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation.
    Bian H; Harris PE; Reed EF
    Int Immunol; 1998 Sep; 10(9):1315-23. PubMed ID: 9786431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transient perturbation of endothelial integrity induced by natural antibodies and complement.
    Saadi S; Platt JL
    J Exp Med; 1995 Jan; 181(1):21-31. PubMed ID: 7807003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accommodation and antibodies.
    Dehoux JP; Gianello P
    Transpl Immunol; 2009 Jun; 21(2):106-10. PubMed ID: 18973811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue-specific endothelial cell heterogeneity contributes to unequal inflammatory responses.
    Gunawardana H; Romero T; Yao N; Heidt S; Mulder A; Elashoff DA; Valenzuela NM
    Sci Rep; 2021 Jan; 11(1):1949. PubMed ID: 33479269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation.
    Wang Z; Zhang Z; Li Y; Zhang Y; Wei M; Li H; Yang S; Zhou Y; Zhou X; Xing G
    Hypertens Res; 2023 Jul; 46(7):1759-1770. PubMed ID: 37188751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelial phosphoinositide 3-kinase-β inactivation confers protection from immune-mediated vascular injury.
    Masoud AG; Lin J; Zhu LF; Tao K; Ness NW; Kassiri Z; Moore RB; Vanhaesebroeck B; West L; Anderson CC; Oudit GY; Murray AG
    Am J Transplant; 2023 Feb; 23(2):202-213. PubMed ID: 36804130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation.
    Franco-Acevedo A; Comes J; Mack JJ; Valenzuela NM
    Front Transplant; 2023; 2():1146040. PubMed ID: 38993843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of donor-specific anti-HLA antibody on cardiac hemodynamics and graft function 3 years after pediatric heart transplantation: First results from the CTOTC-09 multi-institutional study.
    Webber SA; Chin H; Wilkinson JD; Armstrong BD; Canter CE; Dipchand AI; Dodd DA; Feingold B; Lamour JM; Mahle WT; Singh TP; Zuckerman WA; Rossano JW; Morrison Y; Diop H; Demetris AJ; Bentlejewski C; Mohanakumar T; Odim J; Zeevi A;
    Am J Transplant; 2023 Dec; 23(12):1893-1907. PubMed ID: 37579817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accommodation in allogeneic and xenogeneic organ transplantation: Prevalence, impact, and implications for monitoring and for therapeutics.
    Platt JL; Cascalho M
    Hum Immunol; 2023 Jan; 84(1):5-17. PubMed ID: 36244871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protection of transplants against antibody-mediated injuries: from xenotransplantation to allogeneic transplantation, mechanisms and therapeutic insights.
    Kervella D; Le Bas-Bernardet S; Bruneau S; Blancho G
    Front Immunol; 2022; 13():932242. PubMed ID: 35990687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types.
    Muntjewerff EM; Meesters LD; van den Bogaart G; Revelo NH
    Front Immunol; 2020; 11():605958. PubMed ID: 33384693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissecting Allo-Sensitization After Local Administration of Human Allogeneic Adipose Mesenchymal Stem Cells in Perianal Fistulas of Crohn's Disease Patients.
    Avivar-Valderas A; Martín-Martín C; Ramírez C; Del Río B; Menta R; Mancheño-Corvo P; Ortiz-Virumbrales M; Herrero-Méndez Á; Panés J; García-Olmo D; Castañer JL; Palacios I; Lombardo E; Dalemans W; DelaRosa O
    Front Immunol; 2019; 10():1244. PubMed ID: 31258526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.